Digest Network Come funziona
Network
/
Società
GL
Società

GLOBENEWSWIRE

Di cosa scriviamo

12585 comunicati stampa

Guarda tutti i comunicati
25/12/2025
Finanza
Bitget Closes November with $10B+ Stock Futures Volume and 34K BTC Reserves as UEX Momentum Accelerates
Fonte
Bitget Limited
Emittente
GLOBENEWSWIRE
1.00
0
24/12/2025
Media
Annunci Economici
Qianhai, Shenzhen : un nouveau centre urbain en pleine expansion, un terrain d’essai crucial pour la coopération Guangdong-Hong Kong-Macao
Fonte
Qianhai Shenzhen-Hong Kong Modern Service Industry Cooperation Zone
Emittente
GLOBENEWSWIRE
1.00
0
24/12/2025
Farmaceutica
S&P Global Ratings Upgrades Teva to ‘BB+’ Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive
Fonte
Teva Pharmaceutical Industries Ltd
Emittente
GLOBENEWSWIRE
1.00
0
24/12/2025
Politica Internazionale
Director/PDMR Shareholding
Fonte
The Magnum Ice Cream Company N.V.
Emittente
GLOBENEWSWIRE
1.00
0
23/12/2025
Finanza
Annunci Economici
Management/Organizzazione Aziendale
Les plateformes Movement et KAST permettent à plus de 150 millions de commerçants d’accepter les paiements en stablecoins, avec 4 % de récompenses
Fonte
Move Ind. Inc.
Emittente
GLOBENEWSWIRE
1.00
0
23/12/2025
Finanza
Annunci Economici
Management/Organizzazione Aziendale
Movement y KAST habilitan el gasto con stablecoins en más de 150 millones de comercios, con recompensas del 4%
Fonte
Move Ind. Inc.
Emittente
GLOBENEWSWIRE
1.00
0
23/12/2025
Farmaceutica
Politica Internazionale
Communiqué de presse : Sanofi va acquérir Dynavax et ajouter un vaccin commercialisé contre l’hépatite B pour adultes et un candidat vaccin de phase 1⁄2 contre le zona au pipeline
Fonte
Sanofi Winthrop Industrie
Emittente
GLOBENEWSWIRE
1.00
0
23/12/2025
Farmaceutica
Politica Internazionale
Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline
Fonte
Sanofi Winthrop Industrie
Emittente
GLOBENEWSWIRE
1.00
0
23/12/2025
Farmaceutica
Politica Internazionale
Communiqué de presse : Sanofi fait le point sur la soumission réglementaire du tolebrutinib dans la sclérose en plaques secondaire progressive non-récurrente
Fonte
Sanofi Winthrop Industrie
Emittente
GLOBENEWSWIRE
1.00
0
23/12/2025
Farmaceutica
Politica Internazionale
Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
Fonte
Sanofi Winthrop Industrie
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

GLOBENEWSWIRE

4 Rue Charras 75009 Paris
0033 1 82 88 60 16

Social Media

Seguaci
0
Compatibilità
0